Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€12.88
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | -6.531% | -6.531% | -10.462% |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year